← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #995 OF 1,000 MOST-CITED

Written record not kept of program and validation data

FDA cited this observation 13 times across 12 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs13
BY FISCAL YEAR
FY20252
FY20242
FY20231
FY20222
FY20195
FY20171

How FDA worded it — real examples

A written record of the program along with appropriate validation data has not been maintained in situations where backup data is eliminated by computerization or other automated processes.

Pharbest Pharmaceuticals, Inc. · Farmingdale, New York · Drugs · 2025-09-15

A written record of the program along with appropriate validation data has not been maintained in situations where backup data is eliminated by computerization or other automated processes.

United-Guardian, Inc. · Hauppauge, New York · Drugs · 2025-09-04

A written record of the program along with appropriate validation data has not been maintained in situations where backup data is eliminated by computerization or other automated processes.

Univar Solutions, LLC. · Commerce, California · Drugs · 2024-04-12

A written record of the program along with appropriate validation data has not been maintained in situations where backup data is eliminated by computerization or other automated processes.

ALS Pharma Ltda · Paulinia · Drugs · 2023-11-08

A written record of the program along with appropriate validation data has not been maintained in situations where backup data is eliminated by computerization or other automated processes.

SSM-SLUH, Inc. · Saint Louis, Missouri · Drugs · 2023-02-17

A written record of the program along with appropriate validation data has not been maintained in situations where backup data is eliminated by computerization or other automated processes.

Fragrance Manufacturing, Inc. · Allentown, Pennsylvania · Drugs · 2022-09-14

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharma industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →